The FDA has issued a Class II Recall for the Cartiva SCI. All federal lawsuits have now been consolidated into MDL 3172. If you are suffering, we can help you fight back.

2026 URGENT UPDATE: Following the October 2024 Recall of the Cartiva implant, federal courts have established MDL 3172 to handle the growing number of claims. If you have suffered pain, implant shrinkage, or required revision surgery, the time to file your claim is now.

You were promised a breakthrough. You were told the Cartiva Synthetic Cartilage Implant (SCI) would preserve your motion and end your arthritis pain. Instead, you are likely in more pain now than before the surgery.

You are not alone. Studies now show failure rates as high as 64%—far higher than the 13.5% rate the manufacturer originally claimed. The device is known to shrink, slip into the bone (subsidence), and fail, often leaving patients with no choice but to undergo the very fusion surgery they tried to avoid.

If you or a loved one have been injured by the Cartiva toe implant and would like more information, please contact us for a free consultation.